These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1721980)

  • 1. A multicenter comparison of carvedilol with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.
    Langdon CG; Baxter GA; Young PH
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S51-6. PubMed ID: 1721980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of carvedilol in severe hypertension.
    Ogihara T; Yoshinaga K; Kamahara Y; Ikeda M; Goto Y; Arakawa K; Iimura I; Ishii M; Kokubu T; Takeda T
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S69-72. PubMed ID: 1721983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of carvedilol with atenolol in the treatment of mild-to-moderate essential hypertension. INT-CAR-07 (U.K.) Study Group.
    Young PH
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S82-5. PubMed ID: 1378155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.
    van der Does R; Widmann L; Uberbacher HJ; Hörrmann M; Machwirth M; Stienen U
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S147-52. PubMed ID: 1974506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
    Widmann L; van der Does R; Hörrmann M; Machwirth M
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S143-6. PubMed ID: 1974505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled-release carvedilol in the treatment of essential hypertension.
    Weber MA; Sica DA; Tarka EA; Iyengar M; Fleck R; Bakris GL
    Am J Cardiol; 2006 Oct; 98(7A):32L-38L. PubMed ID: 17023230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol.
    Marchi F; Ciriello G
    Adv Ther; 1995; 12(4):212-21. PubMed ID: 10155349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM
    Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of adding carvedilol to hypertensive patients inadequately treated with diuretics.
    Dupont AG; Schoors DF; Venuti RP
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S153-7. PubMed ID: 1974507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.
    Albergati F; Paternó E; Venuti RP; Boeri D; Lombardo I; Semino S; Viviani GL; Adezati L
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S86-9. PubMed ID: 1378156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension.
    Ogihara T; Ikeda M; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S108-12. PubMed ID: 2454355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
    Bell DS; Bakris GL; McGill JB
    Diabetes Obes Metab; 2009 Mar; 11(3):234-8. PubMed ID: 18564334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS; Tenero DM; Baidoo CA; Campanile AM; Harter AH; Boyle D; Danoff TM
    Am J Cardiol; 2006 Oct; 98(7A):17L-26L. PubMed ID: 17023228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of acebutolol with and without hydrochlorothiazide versus carvedilol with and without hydrochlorothiazide in black patients with mild to moderate systemic hypertension.
    Radevski IV; Valtchanova SP; Candy GP; Tshele EF; Sareli P
    Am J Cardiol; 1999 Jul; 84(1):70-5. PubMed ID: 10404854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.